(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -Researchers appear to have
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -Researchers have converted
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -The age of the father play
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -Genetic factors contribute
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -An experimental cannabis-d
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -Low-dose radiotherapy is a
Cross-sectional, observational study reveals that diagnostic delays and misdiagnoses remain common across CIDP variants
The latest from FLAURA2 and NorthStar presented at ESMO 2025 offers guidance on the use of osimertinib in EGFR-mutated NSCLC.
Alectinib treatment results in large survival gains versus crizotinib in advanced ALK-positive NSCLC, report the ALEX investigators at ESMO 2025.
GDFATHER-NEO: Adding the GDF-15 inhibitor visugromab to nivolumab improves outcomes for patients with MIBC unfit for neoadjuvant chemotherapy.
Final survival analysis of the BladderPath trial supports use of MRI-based staging for patients with suspected muscle-invasive bladder cancer.
HARMONi-6 data show ivonescimab plus chemotherapy improves PFS in advanced squamous non–small-cell lung cancer, as seen at ESMO 2025.
Combining disitamab vedotin with toripalimab is superior to platinum-based chemotherapy in HER2-positive advanced urothelial carcinoma.
Results of OptiTROP-Lung04 show increased survival with sacituzumab tirumotecan in EGFR-mutated non–small-cell lung cancer (NSCLC) at ESMO 2025.
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -Cancer patients who receiv
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -A newer class of cancer dr
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy Lapid(Reuters) -Serious cases of a disorde
By Nancy Lapid(Reuters) -Tiny viruses that only infect and kill bacteria can help treat deadly antibiotic-resistant bloodstream infections with Staphylococcus aureus, resul
